# DAOIB Combined With tDCS for Early-phase Dementia

> **NCT04737096** · PHASE2 · COMPLETED · sponsor: **Chang Gung Memorial Hospital** · enrollment: 97 (actual)

## Conditions studied

- Transcranial Direct Current Stimulation
- Dementia

## Interventions

- **DRUG:** DAOIB
- **DRUG:** Placebo
- **DEVICE:** tDCS

## Key facts

- **NCT ID:** NCT04737096
- **Lead sponsor:** Chang Gung Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-01
- **Primary completion:** 2023-01-02
- **Final completion:** 2023-01-02
- **Target enrollment:** 97 (ACTUAL)
- **Last updated:** 2023-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04737096

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04737096, "DAOIB Combined With tDCS for Early-phase Dementia". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04737096. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*